Driving Healthcare Innovation
30Ventures uses extensive due diligence to select from the best of the Midwest’s recently-seeded ventures that are focused on developing cutting-edge technology that will greatly impact human healthcare. Our principals are integral to the innovation ecosystem and bring deep experience in commercializing innovation.
Focused on 5 critical areas in the biotech and healthcare industry including:
- Medical Device & Imaging
- Biotech Discovery Tools
- Medical Diagnostics
Industrial Water & Chemistry Technology
30Ventures is currently investing a portfolio of companies selected from the best of the 2015-2018 seed class in our target sectors. Our primary focus is in the underserved markets of Wisconsin and the Midwest, with regional entrepreneurial strengths and where the General Partner has deep investing and operating experience.
Learn more about our team led by Managing Director, George Arida, with over 18 years of venture capital experience, Principal, Jacob Smith, with experience at three diverse venture capital funds, and an Investment Advisory Board team of highly talented, industry-specialized professionals.
Read the Latest
Read the latest news and updates about 30Ventures and our portfolio companies
New Venture Funds Featured at July 24 Luncheon
George Arida of 30Ventures and Mike Rodgers of Aurora Health Care’s new venture InvestMKE will discuss their funds, investment…
Fresh Off Launch of First Test, TAI Diagnostics Adds Funding
As TAI Diagnostics presses forward on commercialization of its first product, a test for organ rejection in heart transplant patients, the Wauwatosa, WI-based startup…
TAI Diagnostics Raises $10M, Inks Deal With United Therapeutics
TAI Diagnostics said earlier this week that it had closed a $10 million round of funding and forged a new partnership with United Therapeutics (NASDAQ: UTHR)…
30Ventures brings deep relevant market experience to identify attractive investments in target sectors and build enterprise value toward successful exits.
Interested in Learning More?
To learn more about 30Ventures, contact us today